Crossmark

Antitumor studies on celastrol and its derivatives as RORα agonists and RORγ inhibitors based on Alphafold reverse docking strategy

Published Online: 2024-04-12

Published Print: 2024-05

Authors

Yue, Bangwen https://orcid.org/0000-0001-6799-030X
Wu, Xiuli
Funding

Funding for this research was provided by:

Natural Science Foundation of Ningxia Province (2021AAC03127, 2021AAC03160)
License Information

Text and Data Mining valid from 2024-04-12

Version of Record valid from 2024-04-12
More Information

Article History

Received: 3 February 2024

Accepted: 17 March 2024

First Online: 12 April 2024

Compliance with ethical standards

:

: The authors declare no competing interests.

Document is current